Skip to content
10-Q

Quarterly Report

Cell Source, Inc. CLCS

0001493152-22-034876

← back to feed
Filed
Dec 8, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Dec 5, 2022 35.25M sh
Cash And Equivalents Q3 2022 · Sep 30, 2022 $65.94K
Cash And Equivalents Q3 2022 · Dec 31, 2021 $93.1K
Total Liabilities Q3 2022 · Sep 30, 2022 $12.31M
Total Liabilities Q3 2022 · Dec 31, 2021 $10.14M
Total Assets Q3 2022 · Sep 30, 2022 $360.61K
Total Assets Q3 2022 · Dec 31, 2021 $313.77K
Rd Expense Q3 2022 · Sep 30, 2022 $468.01K
Rd Expense Q3 2022 · Sep 30, 2022 $1.49M
Rd Expense Q3 2022 · Sep 30, 2021 $446.77K
Rd Expense Q3 2022 · Sep 30, 2021 $1.04M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$2.92M
Stockholders Equity Q3 2022 · Sep 30, 2021 −$10.19M
Stockholders Equity Q3 2022 · Jun 30, 2021 −$10.03M
Stockholders Equity Q3 2022 · Mar 31, 2021 −$9.04M
Stockholders Equity Q3 2022 · Dec 31, 2020 −$7.95M
Eps Basic Q3 2022 · Sep 30, 2021 −$0.06
Eps Basic Q3 2022 · Sep 30, 2021 −$0.16
Net Income Q3 2022 · Sep 30, 2021 −$1.8M
Net Income Q3 2022 · Sep 30, 2021 −$4.64M
Net Income Q3 2022 · Jun 30, 2021 −$1.31M
Net Income Q3 2022 · Mar 31, 2021 −$1.52M
Operating Income Q3 2022 · Sep 30, 2021 −$1.32M
Operating Income Q3 2022 · Sep 30, 2021 −$3.43M